Long-term statin users have a 21% increased risk of bladder cancer compared to non-users

This paper was published in Cancer Causes and Control 2013 Apr;24(4):769-76

 

Study title and authors:

Statin use and risk of bladder cancer: a meta-analysis.

Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, Wang GC, Xia SQ, Wu Y, Zheng JH.

Department of Urology, Shanghai Tenth People's Hospital, Tongji University, 301 Yanchang Road, Shanghai, 200072, People's Republic of China.

 

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/23361339

This paper analysed the scientific data between January 1966 and October 2012 to quantify the association between statin use and risk of bladder cancer. A total of 13 studies contributed to the analysis.

The paper found:
(a) Statin users had a 7% increased risk of bladder cancer compared to non-users.
(b) Long-term statin users had a 21% increased risk of bladder cancer compared to non-users.

The data from the analysis shows that statins users have more bladder cancer than non-users.